![Michael Rome](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Rome
Direttore/Membro del Consiglio presso
Remix Therapeutics, Inc.
Profilo
Michael Rome is currently Director at Remix Therapeutics, Inc., Director at Pharvaris GmbH since 2020, Director at XinThera, Inc. since 2021, and Managing Director at Foresite Capital Management LLC since 2016.
Former positions include Director at Maze Therapeutics, Inc. and Alumis, Inc., Director at Pharvaris NV from 2019 to 2020, Independent Director at Theseus Pharmaceuticals, Inc. from 2021 to 2024, Independent Director at Kinnate Biopharma, Inc. from 2019 to 2024, and Director & Vice President at FS Development Corp.
from 2020 to 2021.
Education includes a doctorate from California Institute of Technology and an undergraduate degree from the University of California.
Posizioni attive di Michael Rome
| Società | Posizione | Inizio |
|---|---|---|
Foresite Capital Management LLC
 Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management invests in companies located in the United States. The firm focuses on companies operating across a broad range of sectors and industries. It provides financing for seed and later stage capital requirements. | Investitore di Private Equity | 01/08/2016 |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direttore/Membro del Consiglio | 01/07/2020 |
Remix Therapeutics, Inc.
 Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company develops molecule therapies to modulate RNA processing and address the underlying drivers of diseases | Direttore/Membro del Consiglio | - |
Xinthera, Inc.
 Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Produces novel oncology and immunology drugs | Direttore/Membro del Consiglio | 01/01/2021 |
Precedenti posizioni note di Michael Rome
| Società | Posizione | Fine |
|---|---|---|
| KINNATE BIOPHARMA INC. | Direttore/Membro del Consiglio | 03/04/2024 |
| THESEUS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 14/02/2024 |
| FS DEVELOPMENT CORP. | Direttore/Membro del Consiglio | 01/02/2021 |
| PHARVARIS N.V. | Direttore/Membro del Consiglio | 31/12/2020 |
| ALUMIS INC. | Direttore/Membro del Consiglio | - |
Formazione di Michael Rome
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
54
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foresite Capital Management LLC
Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management invests in companies located in the United States. The firm focuses on companies operating across a broad range of sectors and industries. It provides financing for seed and later stage capital requirements. | Finance |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharvaris NV
 Pharvaris NV BiotechnologyHealth Technology Develops and commercializes oral bradykinin B2 receptor antagonists | Health Technology |
Theseus Pharmaceuticals, Inc.
 Theseus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and supplies drugs for cancer patients | Health Technology |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage precision oncology company | Health Technology |
FS Development Corp.
 FS Development Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company develops molecule therapies to modulate RNA processing and address the underlying drivers of diseases | Health Technology |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders | Health Technology |
Xinthera, Inc.
Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Produces novel oncology and immunology drugs | Health Technology |
